The FDA authorised the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, including those who are 65 and older, and pediatric patients
from Latest News https://ift.tt/38oOXLL
Monday, 9 November 2020
Eli Lilly's Covid-19 antibody drug treatment gets emergency USFDA clearance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment